| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/27/2015 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 50k | $26.19 | $1.3M | See footnotes | 01/26/2015 |
| 01/26/2015 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 28k | $26.12 | $732.3k | See footnotes | 01/26/2015 |
| 01/23/2015 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 61.9k | $25.90 | $1.6M | see footnotes | 01/22/2015 |
| 01/22/2015 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 150k | $25.49 | $3.8M | See footnote | 01/22/2015 |
| 01/21/2015 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 44.3k | $25.22 | $1.1M | See Footnotes | 01/20/2015 |
| 01/20/2015 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 25k | $25.24 | $630.9k | See Footnotes | 01/20/2015 |
| 01/16/2015 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 50k | $25.26 | $1.3M | see footnotes | 01/15/2015 |
| 01/15/2015 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 75k | $25.10 | $1.9M | See footnotes | 01/15/2015 |
| 01/14/2015 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 50k | $25.53 | $1.3M | See Footnote | 01/13/2015 |
| 01/13/2015 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 50k | $25.49 | $1.3M | See Footnote | 01/13/2015 |
| 10/03/2013 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 47.8k | $20.27 | $969.3k | See footnote (2) (3) | 10/03/2013 |
| 10/02/2013 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 40k | $20.32 | $813.1k | See footnote (2) (3) | 10/01/2013 |
| 10/01/2013 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 50k | $20.70 | $1M | See footnote | 10/01/2013 |
| 09/30/2013 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 28.9k | $20.46 | $590.8k | see footnote (2) (3) | 09/27/2013 |
| 09/30/2013 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 25k | $20.38 | $509.6k | see footnote (2) (3) | 09/27/2013 |
| 09/27/2013 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 10k | $20.60 | $206k | see footnote (2) (3) | 09/27/2013 |
| 09/27/2013 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 31.3k | $20.52 | $642.2k | see footnote (2) (3) | 09/27/2013 |
| 09/26/2013 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 68k | $20.37 | $1.4M | see footnote (2) (3) | 09/26/2013 |
| 09/25/2013 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 33.4k | $21.22 | $709.4k | see footnote(2)(3) | 09/24/2013 |
| 09/24/2013 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 14.7k | $21.50 | $315.8k | see footnote(2)3) | 09/24/2013 |
| 09/23/2013 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 27.8k | $21.42 | $596.4k | See footnote (3) (4) | 09/20/2013 |
| 09/20/2013 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | Common Stock | 91.7k | $21.96 | $2M | See footnote (3) (4) | 09/20/2013 |
| 09/19/2013 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 39.8k | $22.15 | $882.4k | See footnote | 09/18/2013 |
| 09/18/2013 | Sagent Pharmaceuticals, Inc. | SGNT | Sale | | 49k | $22.84 | $1.1M | See footnote | 09/18/2013 |
| 08/03/2004 | MORGAN STANLEY EASTERN EUROPE FUND, INC. | RNE | Sale | Common Stock | 5k | $25.44 | $127.2k | | 08/03/2004 |
| 08/03/2004 | MORGAN STANLEY ASIA-PACIFIC FUND, INC. | APF | Sale | Common Stock | 7.4k | $10.55 | $78.5k | | 08/03/2004 |
| 08/03/2004 | MORGAN STANLEY GLOBAL OPPORTUNITY BOND FUND, INC. | MGB | Sale | Common Stock | 7.1k | $7.66 | $54.3k | | 08/03/2004 |
| 08/03/2004 | MORGAN STANLEY INDIA INVESTMENT FUND, INC. | IIF | Sale | Common Stock | 7.2k | $20.50 | $147.6k | | 08/03/2004 |
| 08/03/2004 | Invesco High Yield Investments Fund, Inc. | MSY | Sale | Common Stock | 7.1k | $6.03 | $42.8k | | 08/03/2004 |
| 08/03/2004 | LATIN AMERICAN DISCOVERY FUND, INC. | LDF | Sale | Common Stock | 10.4k | $13.02 | $135.6k | | 08/03/2004 |
| 08/03/2004 | MORGAN STANLEY EMERGING MARKETS DEBT FUND INC | MSD | Sale | Common Stock | 9.5k | $8.61 | $81.4k | | 08/03/2004 |
| 08/03/2004 | MORGAN STANLEY EMERGING MARKETS FUND INC | MSF | Sale | Common Stock | 10.5k | $127,513.00 | $1343.6M | | 08/03/2004 |